M-Ras induces Ral and JNK activation to regulate MEK/ERK-independent gene expression in MCF-7 breast cancer cells.
M-Ras induces Ral and JNK activation to regulate MEK/ERK-independent gene expression in MCF-7 breast cancer cells.
复制标题
DOI:
10.1002/jcb.23458
复制
发表时间:
2012-04
影响因子:
4
通讯作者:
Quilliam, Lawrence A.
中科院分区:
文献类型:
--
作者:
Castro, Ariel F.;Campos, Tania;Babcock, Justin T.;Armijo, Marisol E.;Martinez-Conde, Alfonso;Pincheira, Roxana;Quilliam, Lawrence A.
Constitutive activation of M-Ras has previously been reported to cause morphologic and growth transformation of murine cells, suggesting that M-Ras plays a role in tumorigenesis. Cell transformation by M-Ras correlated with weak activation of the Raf/MEK/ERK pathway, although contributions from other downstream effectors were suggested. Recent studies indicate that signaling events distinct from the Raf/MEK/ERK cascade are critical for human tumorigenesis. However, it is unknown what signaling events M-Ras triggers in human cells. Using constitutively active M-Ras (Q71L) containing additional mutations within its effector binding loop, we found that M-Ras induces MEK/ERK-dependent and -independent Elk1 activation as well as PI3K/Akt and JNK/cJun activation in human MCF-7 breast cancer cells. Among several human cell lines examined, M-Ras-induced MEK/ERK-independent Elk1 activation was only detected in MCF-7 cells, and correlated with Rlf /M-Ras interaction and Ral /JNK activation. Supporting a role for M-Ras signaling in breast cancer, EGF activated M-Ras and promoted its interaction with endogenous Rlf. In addition, constitutive activation of M-Ras induced estrogen-independent growth of MCF-7 cells that was dependent on PI3K/Akt, MEK/ERK and JNK activation. Thus, our studies demonstrate that M-Ras signaling activity differs between human cells, highlighting the importance of defining Ras protein signaling within each cell type, especially when designing treatments for Ras-induced cancer. These findings also demonstrate that M-Ras activity may be important for progression of EGFR-dependent tumors.
登录
查看更多内容
影响因子:
5.3
作者:
Ehrhardt, A;David, MD;Schrader, JW
通讯作者:
Schrader, JW
影响因子:
4.8
作者:
Gao, XL;Satoh, T;Kataoka, T
通讯作者:
Kataoka, T
影响因子:
8
作者:
Kimmelman, A;Tolkacheva, T;Chan, AML
通讯作者:
Chan, AML
影响因子:
50.3
作者:
Chin, Koei;DeVries, Sandy;Gray, Joe W.
通讯作者:
Gray, Joe W.
影响因子:
5.3
作者:
De Ruiter, ND;Wolthuis, RMF;Bos, JL
通讯作者:
Bos, JL